All Articles

Browse the full archive, newest first.

Briefing: Volkswagen Group profits take big hit on Porsche shift

Strategic angle: Strategic readjustment at Porsche and declining sales in key markets impact VW's profits significantly.

Editorial Staff Mar 10

Politics

Briefing: Long lines form at US airports as DHS shutdown slows security checks

Strategic angle: Travelers faced hours-long waits at security checkpoints at airports in Houston and New Orleans due to a partial shutdown of the US Department of Homeland Security.

Editorial Staff Mar 10

Money

Briefing: Trump reiterates threat of a 'friendly takeover' of Cuba as fuel crisis deepens

Strategic angle: The comments come less than a week after Trump suggested that his administration would turn its sights on Havana.

Editorial Staff Mar 10

Money

Briefing: BioNTech Shares Fall After Cofounders Plan Exit, Outlook Misses Forecasts

Strategic angle: BioNTech's stock takes a hit as cofounders announce their departure and the company's outlook fails to meet expectations.

Editorial Staff Mar 10

Money

Briefing: Spirit Airlines to Recall Furloughed Pilots Amid Bankruptcy Exit Plans

Strategic angle: The airline aims to combat pilot attrition by bringing back furloughed aviators as it navigates its financial recovery.

Editorial Staff Mar 10

Money

Briefing: Identity theft can cost you during tax season: It's 'a terrible reverse lottery,' one victim says

Strategic angle: Employment-related identity theft is on the rise. Victims may not find out until tax season.

Editorial Staff Mar 10

Life

Briefing: Amid dueling autism meetings, HHS cancels

Strategic angle: Epilepsy med response, a long-awaited fix to the kidney transplant system, and more health news

Editorial Staff Mar 10

Money

Briefing: Investors’ Confidence Boosted Perimeter Solutions (PRM) in Q4

Strategic angle: Investors’ confidence has positively impacted Perimeter Solutions (PRM) in the fourth quarter.

Editorial Staff Mar 10

Money

Briefing: Here is Why CRISPR Therapeutics (CRSP) Appears so Good

Strategic angle: An analysis of CRISPR Therapeutics' potential in the market.

Editorial Staff Mar 10

Money

Briefing: Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)

Strategic angle: Wedbush maintains a positive outlook on Tango Therapeutics, signaling confidence in its performance.

Editorial Staff Mar 10